SynthesisFrontiers in pharmacology2023

Effectiveness and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a systematic review and meta-analysis.

Songfei Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.